The indirect immunofluorescence technique was used to study the relation between corticotropin-releasing factor (CRF) and GABAergic neurons in the rat hypothalamic paraventricular nucleus (PVN). In colchicine-pretreated animals, glutamic acid decarboxylase (GAD)- and GABA-immunoreactive (IR) neurons were observed within the medial part of the parvocellular division of the PVN as well as surrounding the nucleus itself. In general, the GAD antiserum, as compared to the GABA antiserum, revealed stronger IR cells and a higher number of cells in the PVN. CRF-IR cells were observed throughout the whole rostrocaudal extension of the PVN, but predominantly in its dorsal medial parvocellular part. Adjacent sections stained, respectively, with antisera against CRF, GAD or GABA, revealed overlapping distributional patterns within the parvocellular part of the PVN. Employing a direct double-staining technique with sheep GAD and rabbit CRF antisera, it was demonstrated that both GAD and CRF immunoreactivities occurred in the same neurons, particularly in the dorsomedial aspect of the parvocellular PVN. GAD-positive neurons located in the ventromedial parvocellular PVN, periventricular nucleus and surrounding the PVN lacked CRF immunoreactivity. In addition, with an elution-restaining technique it was possible to demonstrate that also GABA immunoreactivity was present in some CRF neurons in the dorsomedial parvocellular PVN. Intravenous injection of the retrograde tracer Fast Blue resulted in labelling of neurons in the periventricular area and in both the parvocellular and magnocellular division of the PVN. After processing the sections for GAD/CRF immunohistochemistry, it was possible to demonstrate the presence of retrogradely labelled GAD/CRF cells, pointing at a PVN median eminence projection for these neurons. The present findings demonstrate that a subpopulation of the CRF-containing neurons in the parvocellular division of the PVN in addition are GABAergic, thereby indicating a possible corelease of these compounds, presumably in the median eminence. Possible interactions of GABA within the hypothalamo-pituitary-adrenal axis are discussed.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.